A.O. Eseola, et al.
MolecularCatalysis473(2019)110398
2-(Anthracen-9-yl)-4,5-diphenyl-1H-imidazole (3) and 2-(an-
4.8 mmol), aniline (0.52 g, 5.6 mmol) and (1.10 g, 14.3 mol).
Chromatography purification on silica gel was eluted by (i) 100%
chloroform to get the oxazole and then (ii) chloroform with increasing
amount of ethyl acetate.
thracen-9-yl)-1,4,5-triphenyl-1H-imidazole (4): Anthracene-9-car-
baldehyde (1.96 g, 9.5 mmol), benzil (2.00 g, 9.5 mmol), aniline
(1.06 g, 11.4 mmol) and ammonium acetate (2.20 g, 28.6 mmol).
Chromatography purification was by long silica gel column and 20:1
dichloromethane / ethyl acetate.
7 - (0.70 g, 31%) Mp. 176 °C. Selected IR peaks (ATR, cm−1): ν
3050 m (CeH aromatic), 1597(C]N imidazole), 1497vs, 1373vs,
753vs. 1H NMR (400 MHz, CDCl3) δ 8.97 (d, J =6.1 Hz, 1 H), 8.88 (d, J
=8.4 Hz, 1 H), 8.82 (d, J =8.2 Hz, 1 H), 8.50 (s, 1 H), 7.99 (dd, J = 5.8,
3.9 Hz, 2 H), 7.83 – 7.69 (m, 4 H), 7.63 – 7.56 (m, 1 H), 7.48 – 7.41 (m,
4 H), 7.36 – 7.24 (m, 4 H), 7.18 (t, J =7.4 Hz, 1 H), 7.11 (dd, J = 8.1,
6.7 Hz, 2 H). 13C NMR (101 MHz, CDCl3) δ 149.52, 137.51, 132.36,
130.87, 129.35, 129.14, 128.47, 128.40, 127.56, 127.48, 126.61,
3 - (0.4 g, 11%) Mp. 304 °C. Selected IR peaks (ATR, cm−1): ν
3053 m (CeH aromatic), 1625 m (C]C aromatic), 1443s, 733vs, 695vs.
1H NMR (400 MHz, (CD3)2SO) δ 12.96 (s, 1 H), 8.80 (s, 1 H), 8.23–8.17
(m, 2 H), 7.99–7.93 (m, 2 H), 7.69 (d, J =7.4 Hz, 2 H), 7.59 (dd,
J = 10.0, 5.6 Hz, 6 H), 7.44 (t, J =7.1 Hz, 2 H), 7.36 (t, J =7.1 Hz,
3 H), 7.28 (d, J =7.0 Hz, 1 H). 13C NMR (101 MHz, (CD3)2SO) δ
143.75, 137.42, 135.91, 131.60, 131.38, 131.29, 129.20, 128.88,
128.74, 128.43, 128.19, 128.05, 127.80, 127.08, 126.49, 126.05. MS
(EI) m/z 396 (M+, 100%): 396, 351, 168.
126.40, 125.92, 125.29, 124.19, 123.19, 121.13. MS (EI) m/z 470 (M+
,
100%): 470, 393, 266.
9 - (0.5 g, 26%) Mp. 308 °C. Selected IR peaks (ATR, cm−1): ν
3054 m (CeH aromatic), 1619 m (C]C aromatic), 1477vs, 1349vs,
775vs. 1H NMR (400 MHz, CDCl3) δ 8.87 (dd, J = 11.1, 4.8 Hz, 2 H),
8.81 – 8.76 (m, 1 H), 8.73 (s, 1 H), 8.39 – 8.35 (m, 1 H), 8.20 – 8.13 (m,
4 H), 7.84 – 7.81 (m, 1 H), 7.77 (m, 3 H), 7.59 – 7.53 (m, 4 H). 13C NMR
(101 MHz, CDCl3) δ 131.21, 128.69, 127.39, 125.60, 115.00. MS (EI)
m/z 395 (M+, 100%): 395, 365, 203, 163.
4 - (2.6 g, 58%) Mp. 237 °C. Selected IR peaks (ATR, cm−1): ν
3054 w (CeH aromatic), 1625 m (C]C aromatic), 1596s, 1494vs,
699vs. 1H NMR (400 MHz, CDCl3) δ 8.48 (s, 1 H), 7.99–7.96 (m, 2 H),
7.87 (d, J =8.0 Hz, 2 H), 7.76 (d, J =7.3 Hz, 2 H), 7.49 – 7.41 (m, 4 H),
7.30 (dd, J = 13.0, 6.1 Hz,8 H), 7.28 – 7.22 (m, 1 H), 6.85–6.77 (m,
4 H). 13C NMR (101 MHz, CDCl3) δ 145.11, 132.26, 131.02, 130.99,
129.86, 128.53, 128.43, 128.24, 127.58, 127.05, 126.45, 126.05,
125.21. MS (EI) m/z 472 (M+, 100%): 472, 395, 236, 165.
Preparation of palladium complexes
2-(Anthracen-9-yl)-1,4,5-tris(4-methoxyphenyl)-1H-imidazole
(5): Anthracene-9-carbaldehyde (0.76 g, 3.7 mmol), 1,2-bis(4-methox-
yphenyl)ethane-1,2-dione (1.00 g, 3.7 mmol), 4-methoxyaniline
(0.55 g, 4.4 mmol) and ammonium acetate (0.86 g, 11.1 mmol). Crude
product was purified by recrystallization in chloroform / hexane. (Yield
=1.2 g, 58%). Mp. 298 °C. Selected IR peaks (ATR, cm−1): ν 3062 w
(CeH aromatic), 2959 m (methyl), 1610s (C]C aromatic), 1513vs,
1245vs, 1029vs. 1H NMR (400 MHz, CDCl3) δ 8.46 (s, 1 H), 8.00–7.93
(m, 2 H), 7.83 (d, J =7.0 Hz, 2 H), 7.68 (d, J =8.2 Hz, 2 H), 7.48 – 7.39
(m, 4 H), 7.22–7.19 (m, 2 H), 6.85 (dd, J = 8.6, 6.4 Hz, 4 H), 6.74 (d, J
General procedure: A given amount of ligand and one or half
equivalent of either bis(acetonitrile)dichloridopalladium(II), bis(ben-
zonitrile)dichloridopalladium(II) or palladium acetate were weighed
into a glass vial. After addition of solvent, which was either acetonitrile,
ethanol or methanol, the vial is sealed and allowed to stand without
disturbance for at least overnight in order to allow self-assemble of the
preferred coordination product. The complexation product was filtered
off, washed with little amount of the utilized solvent and dried to obtain
solids of varying colour from yellow through orange to brown crystal-
line or amorphous materials. For several complexation experiments,
suitable single crystals were obtained and analysed for structural in-
formation. The individual synthetic and analytical data for all the iso-
lated coordination products are listed below. Each complexation ex-
periment was routinely monitored by microscope to optically observe
complete disappearance of ligand or palladium salt solids before fil-
tering the formed complex. Therefore, some of the complexation ex-
periments stood for several days before product filtration.
=8.9 Hz, 2 H), 6.32 (d, J =8.9 Hz, 2 H), 3.82 (s, 6 H), 3.50 (s, 3 H). 13
C
NMR (101 MHz, CDCl3) δ 132.27, 131.01, 130.90, 128.41, 128.12,
125.17, 118.14, 114.00, 113.66, 113.43, 55.23, 55.16, 54.99, 41.01.
MS (EI) m/z 562 (M+, 100%): 562, 455, 396, 281.
2-Mesityl-1-phenyl-1H-phenanthro[9,10-d]imidazole (6) and 2-me-
sitylphenanthro [9,10-d]oxazole (8): 2,4,6-Trimethylbenzaldehyde
(0.71 g, 4.8 mmol), phenanthrene-9,10-dione (1.00 g, 4.8 mmol), aniline
(0.53 g, 5.7 mmol) and (1.10 g, 14.3 mmol). Chromatography was done
on silica gel eluted by (i) 1:1 chloroform / n-hexane and (ii) 6:1 n-hep-
tane / ethyl acetate.
1-PdCl2MeCN:
4,5-Diethyl-2-mesityl-1H-imidazole
(48 mg,
0.20 mmol), PdCl2(MeCN)2 (26 mg, 0.20 mmol). (Yield =11 mg, 12%).
Mp. with decomposition > 300 °C Selected IR peaks (ATR, cm−1): ν
3179vs (N–H), 2972s (C–H alkyl), 1616s (C]C aromatic), 1436vvs,
850vs, 771vs. 1H NMR (300 MHz, (CD3)2SO) δ 12.41 (s, 1 H), 6.96 (s,
2 H), 2.97 (q, J =7.5 Hz, 2 H), 2.31 (s, 3 H), 2.11 (s, 6 H), 2.06 (s, 3 H),
1.43 (t, J =7.5 Hz, 3 H), 1.08 (m, 5 H). Anal. calc. for C18H25Cl2N3Pd:
C, 46.92; H, 5.47; N, 9.12%. Found: C, 46.97; H, 5.46; N, 9.07%.
12-PdCl2: 4,5-Diethyl-2-mesityl-1H-imidazole (48 mg, 0.20 mmol),
PdCl2(MeCN)2 (13 mg, 0.10 mmol). (Yield =21 mg, 32%). Mp. with
decomposition > 300 °C. Selected IR peaks (ATR, cm−1): ν 3283vs
(N–H), 2970vs (C–H alkyl), 1616vs (C]C aromatic), 1436vvs, 860vs,
693vs. 1H NMR (300 MHz, (CD3)2SO) δ 12.06 (s, 1 H), 11.98 (s, 1 H),
6.95 (s, 2 H), 6.79 (s, 2 H), 3.12 (dd, J = 14.0, 6.6 Hz, 2 H), 2.73 – 2.66
(m, 2 H), 2.43 (s, 3 H), 2.41 (m, 3 H), 2.32 (s, 3 H), 2.13 (s, 6 H), 1.82 (s,
6 H), 1.56 (t, J =7.5 Hz, 3 H), 1.12 – 1.00 (m, 10 H). Anal. calc. for
6 - (0.6 g, 30%) Mp. 216 °C. Selected IR peaks (ATR, cm−1): ν
2920 w (CeH alkyl), 1611s (C]C aromatic), 1496vs, 1452vs, 1376vs,
697vs. 1H NMR (400 MHz, (CD3)2SO) δ 8.93 (d, J =8.3 Hz, 1 H), 8.88
(d, J =8.3 Hz, 1 H), 8.63 (dd, J = 7.9, 1.2 Hz, 1 H), 7.79 – 7.73 (m,
1 H), 7.68 (ddd, J = 8.4, 7.2, 1.4 Hz, 1 H), 7.60 – 7.46 (m, 6 H), 7.37 –
7.31 (m, 1 H), 7.08 (dd, J = 8.3, 0.8 Hz, 1 H), 6.86 (s, 2 H), 2.21 (s,
3 H), 2.06 (s, 6 H). 13C NMR (101 MHz, (CD3)2SO) δ 151.30, 139.03,
138.20, 137.79, 137.20, 130.29, 130.18, 128.77, 128.07, 128.04,
127.94, 127.87, 127.29, 127.04, 126.86, 126.08, 125.59, 124.92,
124.10, 122.91, 122.57, 120.78, 21.18, 20.36. MS (EI) m/z 412 (M+
,
100%): 412, 397, 335, 266, 206.
8 - (0.6 g, 37%) Mp. 313 °C. Selected IR peaks (ATR, cm−1): ν
3069 w (CeH aromatic), 2962 m (CeH alkyl), 1614s (C]C aromatic),
1468vs, 743vs, 721vs. 1H NMR (400 MHz, (CD3)2SO) δ 9.00 (t, J
=9.1 Hz, 2 H), 8.50 (dd, J = 7.8, 1.2 Hz, 1 H), 8.33 – 8.28 (m, 1 H),
7.86 – 7.76 (m, 4 H), 7.12 (s, 2 H), 2.37 (s, 3 H), 2.34 (s, 6 H). 13C NMR
(101 MHz, (CD3)2SO) δ 161.99, 155.18, 140.62, 138.62, 137.91,
134.44, 131.54, 129.18, 129.09, 128.84, 128.43, 127.52, 127.02,
125.90, 124.79, 124.62, 122.79, 121.17, 121.03, 120.79, 120.13,
21.33, 20.62. MS (EI) m/z 337 (M+, 100%): 337, 321, 308, 294, 163.
2-(Anthracen-9-yl)-1-phenyl-1H-phenanthro[9,10-d]imidazole (7)
and 2-(anthracen-9-yl)phenanthro[9,10-d]oxazole (9): Anthracene-9-
carbaldehyde (0.98 g, 4.8 mmol), phenanthrene-9,10-dione (1.00 g,
C
32H44Cl2N4Pd: C, 58.05; H, 6.70; N, 8.46%. Found: C, 58.12; H, 6.83;
N, 8.49%.
12-Pd(OAc)2:
4,5-Diethyl-2-mesityl-1H-imidazole
(48 mg,
0.20 mmol), Pd(OAc)2 (22 mg, 0.10 mmol). (Yield =43 mg, 61%). Mp.
311 °C. Selected IR peaks (ATR, cm−1): ν 2969s (C–H alkyl), 1618 m
(C = C aromatic), 1588vs (C = N), 1386vs, 1311vs, 853 s, 700 s. 1H
NMR not obtained due to poor solubility. Anal. calc. for C36H50N4O4Pd:
C, 60.97; H, 7.11; N, 7.90. Found: C, 60.79; N, 6.99; N, 7.77.
2-PdCl2MeCN: 2-(Anthracen-9-yl)-4,5-diethyl-1H-imidazole (60 mg,
4